FredericMWaldmanMD

Anatomic Pathology, Clinical Pathology

Medical Director, Cancer Diagnostics Quest Diagnostics Nichols Institute

Dr. Waldman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
1600 Divisadero St
San Francisco, CA 94143
Phone+1 415-353-7241

Fax+1 415-476-4150

University of California (San Francisco)Residency, Pathology-Anatomic and Clinical, 1980 - 1984
New York University School of MedicineClass of 1980

PubMed

8226 citations
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt, Robert S. Fulton, Michael D. McLellan, Heather Schmidt, Joelle Kalicki-Veizer
Nature. 2012-10-04
33 citations
Comparison of genetic changes in schistosome-related transitional and squamous bladder cancers using comparative genomic hybridization.
Michael Muscheck, H. Abol-Enein, Karen Chew, Dan H. Moore, Vivek Bhargava
Carcinogenesis. 2000-09-01
2393 citations
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes
Richard M. Neve, Koei Chin, Jane Fridlyand, Jennifer Yeh, Frederick L. Baehner
Cancer Cell. 2006-12-01

With Fall 2017 Cycle, UCSF’s Resource Allocation Program (RAP) Celebrates 10 Years of FundingAugust 25th, 2017

Immunohistochemistry And Molecular PathologyNational Cancer Institute2007–2011
Predictive Markers In Metastatic Renal CancerNational Cancer Institute2008–2010
Bladder Cancer Risk And Genomic AlterationsNational Cancer Institute2007–2010
Renal Cancer Genomic Alterations And Environmental Risk(Rmi)National Cancer Institute2007
Renal Cancer Genomic Alterations And Environmental RiskNational Cancer Institute2003–2006
Renal Cancer Genomic Alterations-Environmental Risk(Rmi)National Cancer Institute2005
Genomic Markers Of Colon Cancer ProgressionNational Cancer Institute2001–2005
Genetic Markers Of Bladder Cancer ProgressionNational Cancer Institute2001–2005
Core--Immunohistochemistry/Molecular Pathology FacilityNational Cancer Institute2002
Molecular/Cellular Predictors Of Breast Cancer PrognosisNational Cancer Institute1999–2000
Breast Cancer Molecular CytogeneticsNational Cancer Institute1996–2000
Neoplastic Progression In Ulcerative ColitisNational Cancer Institute1997–1999
Cytometric And Other Markers Of Bladder CancerNational Cancer Institute1994–1999
Molecular/Cellular Predictors Of Breast Cancer PrognosisNational Cancer Institute1997–1998
Breast Cancer Molecular CytogeneticsNational Cancer Institute1995–1998
Cytometric And Other Markers Of Human Bladder CancerNational Cancer Institute1992–1993
Fluorescent Nuclear Organization--In Situ HybridizationNational Cancer Institute1989–1993